-
Infigratinib is an
kinase inhibitor in
development for the
treatment of
achondroplasia and hypochondroplasia.
Infigratinib targets the
fibroblast growth...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
-
Fibroblast growth factor receptor (FGFR)
inhibitors Erdafitinib ****ibatinib
Infigratinib Pemigatinib Cabozantinib Capmatinib Entrectinib Gilteritinib Larotrectinib...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
-
Trafermin Antibodies:
Aprutumab Aprutumab ixadotin Kinase inhibitors:
Infigratinib FGFR3 Agonists:
Ersofermin FGF (1, 2 (bFGF), 4, 8, 9, 18, 23) Selpercatinib...
- L01EM05
Parsaclisib L01EN01
Erdafitinib L01EN02
Pemigatinib L01EN03
Infigratinib L01EN04 ****ibatinib L01EX01
Sunitinib L01EX02
Sorafenib L01EX03 Pazopanib...
